VERAPAMIL HYDROCHLORIDE

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 71209-047
  • Package NDC 71209-047-05
  • Package NDC 71209-047-10
  • Application number ANDA206173
  • SPL ID d6b80b6c-59f6-4e63-bb8d-a29a77f4a0a1
  • SPL set ID 5501208c-aa2b-47aa-89f7-87f4d4a73fd0
  • UNII V3888OEY5R
  • RxCUI 897640
  • RxCUI 897649
  • RxCUI 897659

What the source publishes

Labeler
Cadila Pharmaceuticals Limited
Active ingredients
verapamil hydrochloride
Form
TABLET, EXTENDED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:71209-047_d6b80b6c-59f6-4e63-bb8d-a29a77f4a0a1
{
  "name": "VERAPAMIL HYDROCHLORIDE",
  "splId": "d6b80b6c-59f6-4e63-bb8d-a29a77f4a0a1",
  "labels": [
    {
      "setId": "5501208c-aa2b-47aa-89f7-87f4d4a73fd0",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5501208c-aa2b-47aa-89f7-87f4d4a73fd0",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5501208c-aa2b-47aa-89f7-87f4d4a73fd0"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Cadila Pharmaceuticals Limited",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71209-047-05)",
      "package_ndc": "71209-047-05",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20170527"
    },
    {
      "sample": false,
      "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (71209-047-10)",
      "package_ndc": "71209-047-10",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20200214"
    }
  ],
  "productId": "71209-047_d6b80b6c-59f6-4e63-bb8d-a29a77f4a0a1",
  "useDomain": "unknown",
  "dosageForm": "TABLET, EXTENDED RELEASE",
  "productNdc": "71209-047",
  "deaSchedule": null,
  "genericName": "verapamil hydrochloride",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "VERAPAMIL HYDROCHLORIDE",
      "strength": "180 mg/1"
    }
  ],
  "applicationNumber": "ANDA206173",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20170527",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0371209048101",
      "0371209047104",
      "0371209047050"
    ],
    "unii": [
      "V3888OEY5R"
    ],
    "rxcui": [
      "897640",
      "897649",
      "897659"
    ],
    "spl_set_id": [
      "5501208c-aa2b-47aa-89f7-87f4d4a73fd0"
    ],
    "manufacturer_name": [
      "Cadila Pharmaceuticals Limited"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:71209-047_d6b80b6c-59f6-4e63-bb8d-a29a77f4a0a1"